| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activities of anti-murine cytomegalovirus (MCMV) immunotoxins used alone or in combination with antiviral agents against MCMV infections
|
|
|
1995
|
26 |
3 |
p. A323-
1 p.
|
artikel
|
| 2 |
Activity of AZT and ddI when used in combination with other mechanistically diverse inhibitors of HIV replication
|
|
|
1995
|
26 |
3 |
p. A255-
1 p.
|
artikel
|
| 3 |
Activity of hydroxyurea (HU) in combination with several antiviral nucleosides against in vitro replication of herpes simplex type 1 (HSV-1) and type 2 (HSV-2) and varicella-zoster virus (VZV)
|
Snoeck, R.
|
|
1995
|
26 |
3 |
p. A315-
1 p.
|
artikel
|
| 4 |
Acyclovir, as a tool to differentiate between mutants of herpes simplex virus, in mixed infections
|
|
|
1995
|
26 |
3 |
p. A313-
1 p.
|
artikel
|
| 5 |
Adjuvant effect of imiquimod when combined with HSV glycoprotein vaccine in guinea pigs with recurrent HSV-2 genital herpes
|
|
|
1995
|
26 |
3 |
p. A233-
1 p.
|
artikel
|
| 6 |
Analysis of mutations in the thymidine kinase gene of varicella-zoster virus associated with resistance to 5-iodo-2′-deoxyuridine (IDU) and 5-bromo-2′-deoxyuridine (BrDU)
|
Kodama, E.
|
|
1995
|
26 |
3 |
p. A324-
1 p.
|
artikel
|
| 7 |
An antiviral synthetic coiled-coil peptide displays sustained blood levels in rats
|
|
|
1995
|
26 |
3 |
p. A351-
1 p.
|
artikel
|
| 8 |
3′ → 5′ and 5′ → 5′ uridine-AZT phosphodiester dimers: Synthesis and in vitro anti-HIV activities
|
Imbach, J.-L.
|
|
1995
|
26 |
3 |
p. A259-
1 p.
|
artikel
|
| 9 |
A new synthesis of 2′-deoxypyrimidine nucleosides involving sodium cyanoborohydride
|
Almond, M.R.
|
|
1995
|
26 |
3 |
p. A248-
1 p.
|
artikel
|
| 10 |
Anti-HIV activities of new PETT compounds in cell cultures
|
Öberg, B.
|
|
1995
|
26 |
3 |
p. A236-
1 p.
|
artikel
|
| 11 |
Anti-HIV activity of bovine seminal RNase
|
La Colla, P.
|
|
1995
|
26 |
3 |
p. A263-
1 p.
|
artikel
|
| 12 |
Anti-HIV agent 935U83 — Preliminary clinical assessment
|
Daluge, S.M.
|
|
1995
|
26 |
3 |
p. A287-
1 p.
|
artikel
|
| 13 |
Anti-influenzavirus-activities of polyoxometalates
|
Shigeta, S.
|
|
1995
|
26 |
3 |
p. A298-
1 p.
|
artikel
|
| 14 |
Anti-picornavirus activity of new substituted flavons and flavanones
|
Tomao, P
|
|
1995
|
26 |
3 |
p. A346-
1 p.
|
artikel
|
| 15 |
Antipicornavirus activity of SCH 47802: In vitro and in vivo studies
|
|
|
1995
|
26 |
3 |
p. A345-
1 p.
|
artikel
|
| 16 |
Anti-respiratory syncytial virus activity of selected polyoxometalates
|
Barnard, D.L.
|
|
1995
|
26 |
3 |
p. A349-
1 p.
|
artikel
|
| 17 |
Anti-retroviral activities of baicalin in vitro and in vivo
|
|
|
1995
|
26 |
3 |
p. A272-
1 p.
|
artikel
|
| 18 |
Antiretroviral activity of ribonucleotide reductase inhibitors hydroxyurea, didox and trimidox in the in vivo Rauscher murine leukemia virus (RMuLV) model
|
|
|
1995
|
26 |
3 |
p. A275-
1 p.
|
artikel
|
| 19 |
Antiviral activity of CH31 against HHV-6 in vitro
|
Yang, Hui-wu
|
|
1995
|
26 |
3 |
p. A359-
1 p.
|
artikel
|
| 20 |
Antiviral activity of compounds against human herpesvirus 6
|
Takahashi, K.
|
|
1995
|
26 |
3 |
p. A326-
1 p.
|
artikel
|
| 21 |
Antiviral activity of nucleoside derivatives against acyclovir-resistant mutants of herpes simplex virus type 1
|
Lee, Chong-Kyo
|
|
1995
|
26 |
3 |
p. A311-
1 p.
|
artikel
|
| 22 |
Antiviral activity of phosphinic cyclocreatine (2-iminoimidazolidine-1-methyl phosphinic acid) against HCMV and HSV-1
|
Mulamba, B.G.
|
|
1995
|
26 |
3 |
p. A317-
1 p.
|
artikel
|
| 23 |
Antiviral activity of 2-phosphonomethoxyalkyl derivatives of N6-substituted 6-aminopurines
|
Holý, A.
|
|
1995
|
26 |
3 |
p. A231-
1 p.
|
artikel
|
| 24 |
Antiviral activity of selected nucleoside analogues against human herpes virus type 6
|
Reymen, D.
|
|
1995
|
26 |
3 |
p. A326-
1 p.
|
artikel
|
| 25 |
Antiviral agents reduce viral load and delay the detection of infected cells in vivo in the HIV-infected Hu-PBMC SCID mouse model
|
|
|
1995
|
26 |
3 |
p. A238-
1 p.
|
artikel
|
| 26 |
Antiviral and immunomodulating activities of the imidazoquinoline S-28463
|
|
|
1995
|
26 |
3 |
p. A301-
1 p.
|
artikel
|
| 27 |
Antiviral drug susceptibility of herpes simplex type 1 (HSV-1) strains emerging under the selective pressure of (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)cytosine (HPMPC) in vitro
|
Andrei, G.
|
|
1995
|
26 |
3 |
p. A312-
1 p.
|
artikel
|
| 28 |
Antiviral effect of coumarin analogue against respiratory syncytical virus infection in vitro and in vivo
|
Yang, ZQ.
|
|
1995
|
26 |
3 |
p. A350-
1 p.
|
artikel
|
| 29 |
Antiviral effect on infectious pancreatic necrosis virus replication
|
Jashés, M.
|
|
1995
|
26 |
3 |
p. A355-
1 p.
|
artikel
|
| 30 |
Antiviral efficacy in mice of oral bis(POM)-PMEA, the Bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine
|
Naesens, L.
|
|
1995
|
26 |
3 |
p. A276-
1 p.
|
artikel
|
| 31 |
Antiviral properties of sterically hindered phenol derivatives
|
Andreeva, O.T.
|
|
1995
|
26 |
3 |
p. A316-
1 p.
|
artikel
|
| 32 |
Antiviral resistance to enantiomers of 2′,3′-dideoxycytidine analogues — Common threads
|
|
|
1995
|
26 |
3 |
p. A267-
1 p.
|
artikel
|
| 33 |
A pharmacokinetic/pharmacodynamic approach for the comparison of penciclovir and acyclovir: Utilization of an in vitro model which simulates in vivo pharmacokinetics
|
|
|
1995
|
26 |
3 |
p. A338-
1 p.
|
artikel
|
| 34 |
Aporphinoid alkaloid glaucinone: A selective inhibitor of poliovirus replication
|
Galabov, A.S.
|
|
1995
|
26 |
3 |
p. A347-
1 p.
|
artikel
|
| 35 |
A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo
|
|
|
1995
|
26 |
3 |
p. A230-
1 p.
|
artikel
|
| 36 |
Application of microdialysis to the study of antiviral drug pharmacokinetics in humans: validation of subcutaneous extracellular sampling of zidovudine
|
Ståthle, L
|
|
1995
|
26 |
3 |
p. A285-
1 p.
|
artikel
|
| 37 |
A randomized, controlled trial of zovirax* (acyclovlr, ACV) versus netivudine for the treatment of herpes zoster
|
|
|
1995
|
26 |
3 |
p. A297-
1 p.
|
artikel
|
| 38 |
A randomized, double-blind, placebo-controlled phase I/II evaluation of 9-[2-(bispivaloyloxy-methyl) phosphonyl-methoxy]adenine (bis-POM PMEA), an orally bioavailable prodrug of the anti-HIV nucleotide, PMEA
|
|
|
1995
|
26 |
3 |
p. A229-
1 p.
|
artikel
|
| 39 |
A randomized, double-blind study of the efficacy and safety of oral ganciclovir for the prevention of cytomegalovirus disease in HIV-infected persons
|
|
|
1995
|
26 |
3 |
p. A343-
1 p.
|
artikel
|
| 40 |
A retrometabolic concept: The pronucleotide approach
|
Imbach, J.-L.
|
|
1995
|
26 |
3 |
p. A273-
1 p.
|
artikel
|
| 41 |
AZT metabolism and toxicity: Application of 5-azido-3′-azido-2′,3′-dideoxyuridine monophosphate, a photoaffinity analog of AZT-monophosphate
|
|
|
1995
|
26 |
3 |
p. A265-
1 p.
|
artikel
|
| 42 |
[AZT]-[TSAO-T] and [AZT]-[HEPT] heterodimers as potential bi-functional inhibitors of HIV-1 reverse transcriptase, synthesis, structural assignment and Anti-HIV activity
|
Camarasa, M.J.
|
|
1995
|
26 |
3 |
p. A257-
1 p.
|
artikel
|
| 43 |
Cationic liposome-mediated delivery of anti-HIV-1 ribozyme to chronically infected cells
|
Konopka, K.
|
|
1995
|
26 |
3 |
p. A266-
1 p.
|
artikel
|
| 44 |
Cellular pharmacology of β - L - dideoxycytidine, β - L - 2′, 3′ dideoxy - 5 - fluorocytidine, and β - D - 2′, 3′ dideoxy - 5 - fluorocytidine
|
|
|
1995
|
26 |
3 |
p. A241-
1 p.
|
artikel
|
| 45 |
Chain terminated hepadnavirus genomes are released as complete extracellular virions: Are serum virion DNA levels a true measure of drug efficacy?
|
|
|
1995
|
26 |
3 |
p. A291-
1 p.
|
artikel
|
| 46 |
Characterization of a cellular line expressing a defect of thymidine kinase activity and displaying resistance to the antiviral activity of AZT
|
Antonelli, G.
|
|
1995
|
26 |
3 |
p. A269-
1 p.
|
artikel
|
| 47 |
Characterization of HIV-1 reverse transcriptase encoding mutations at the amino acid residues 161 and 208 involved in phosphonoformate resistance
|
Tramontano, E.
|
|
1995
|
26 |
3 |
p. A268-
1 p.
|
artikel
|
| 48 |
Characterization of siamycin I, an HIV fusion inhibitor
|
Lin, P.-F.
|
|
1995
|
26 |
3 |
p. A260-
1 p.
|
artikel
|
| 49 |
Characterization of the anti-HIV-1 activity of DABOs
|
Loi, A.G.
|
|
1995
|
26 |
3 |
p. A263-
1 p.
|
artikel
|
| 50 |
Characterization of the guinea pig cytomegalovirus UL97 gene homologue
|
Fox, D.S.
|
|
1995
|
26 |
3 |
p. A322-
1 p.
|
artikel
|
| 51 |
Chemoenzymatic synthesis of carbocyclic nucleotide mimics possessing potent activity against HIV-reverse transcriptase
|
Clements, C.J.
|
|
1995
|
26 |
3 |
p. A248-
1 p.
|
artikel
|
| 52 |
ChemoimmunotherapyCI) by thiophenoyl urea(TUR) & Nonvirion antigen vaccine (NVA) for AIDS patients
|
|
|
1995
|
26 |
3 |
p. A286-
1 p.
|
artikel
|
| 53 |
Civamide (CIV) treatment of primary and recurrent experimental genital herpes
|
|
|
1995
|
26 |
3 |
p. A335-
1 p.
|
artikel
|
| 54 |
Cloning, purification and biochemical characterization of HIV-2 reverse transcriptase (RT) and comparison with endogenous HIV-2 RT
|
Piras, G.
|
|
1995
|
26 |
3 |
p. A270-
1 p.
|
artikel
|
| 55 |
Colorimetric assay system for screening antiviral compounds against hepatitis B virus
|
Sudo, Kenji
|
|
1995
|
26 |
3 |
p. A289-
1 p.
|
artikel
|
| 56 |
Combination of azidothymidine (AZT) with (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) leads to inhibition of the in vitro replication of herpes simplex virus type 1 (HSV-1), type 2 (HSV-2) and varicella-zoster virus (VZV) strains that are deficient in thymidine kinase (TK) activity
|
Andrei, G.
|
|
1995
|
26 |
3 |
p. A324-
1 p.
|
artikel
|
| 57 |
Combined antiviral effect of flavonoid and acyclovir
|
Béládi, Ilona
|
|
1995
|
26 |
3 |
p. A256-
1 p.
|
artikel
|
| 58 |
Comparative effects of famciclovir and valaciclovir on cutaneous and neurological HSV-1 infection in normal and immunocompromised mice
|
|
|
1995
|
26 |
3 |
p. A328-
1 p.
|
artikel
|
| 59 |
Comparative evaluation of the plaque reduction assay and a microplate ELISA test for antiviral susceptibility testing of herpes simplex virus (HSV) isolates
|
|
|
1995
|
26 |
3 |
p. A310-
1 p.
|
artikel
|
| 60 |
Comparative inhibitory effects of ribavirin, pyrazofurin, and EICAR on measles (SSPE) virus replication in vitro and in vivo
|
Hosoya, M.
|
|
1995
|
26 |
3 |
p. A351-
1 p.
|
artikel
|
| 61 |
Comparison of efficacy and toxicity of HPMPC and cyclic HPMPC in animal models for severe herpesvirus infections
|
|
|
1995
|
26 |
3 |
p. A329-
1 p.
|
artikel
|
| 62 |
Comparison of n-docosanol cream (LIDAKOL™) with acyclovir ointment (Zovirax™) in the inhibition of cutaneous herpes simplex virus (HSV) infections in two guinea pig model systems
|
|
|
1995
|
26 |
3 |
p. A333-
1 p.
|
artikel
|
| 63 |
Comparison of the antiviral efficacy of acyclovir and penciclovir in topically treated HSV-infected HRS/J mice
|
|
|
1995
|
26 |
3 |
p. A328-
1 p.
|
artikel
|
| 64 |
Competitive Elisa for D4T: Application to clinical pharmacology
|
Guedj, R.
|
|
1995
|
26 |
3 |
p. A284-
1 p.
|
artikel
|
| 65 |
Covariates in herpes zoster and interpretation of clinical trial data
|
Dworkin, R.H.
|
|
1995
|
26 |
3 |
p. A344-
1 p.
|
artikel
|
| 66 |
Coxsackievirus B3 mutants resistant to WIN 63843 are attenuated for virulence in mice: Molecular analysis of the drug resistant phenotype
|
|
|
1995
|
26 |
3 |
p. A300-
1 p.
|
artikel
|
| 67 |
Creatine phosphate inhibits the replication of HIV in macrophages
|
Hansen, L.J.
|
|
1995
|
26 |
3 |
p. A264-
1 p.
|
artikel
|
| 68 |
Cyclosporin A modulation of primary simian immunodeficiency virus (SIV) infection in rhesus monkeys
|
|
|
1995
|
26 |
3 |
p. A227-
1 p.
|
artikel
|
| 69 |
2′-deoxy-4′-thio purine nucleosides as potent inhibitors of HBV and HCMV
|
|
|
1995
|
26 |
3 |
p. A288-
1 p.
|
artikel
|
| 70 |
Development of a non-hazardous biological assay system for the screening of anti-HIV compounds
|
Kiser, R.
|
|
1995
|
26 |
3 |
p. A252-
1 p.
|
artikel
|
| 71 |
Development of anti-HSV screening system using suspension cell line and screening several nucleoside analogues in this method
|
|
|
1995
|
26 |
3 |
p. A309-
1 p.
|
artikel
|
| 72 |
Development of HSV-2 type-specific antibodies to glycoprotein B in HSV-2 seronegative individuals following immunization with a recombinant gB2/gD2/adjuvant vaccine
|
|
|
1995
|
26 |
3 |
p. A342-
1 p.
|
artikel
|
| 73 |
2′,-dideoxycytidine 5′-triphosphate analogs as substrate for human DNA polymerases: implication for the mechanism of toxicity
|
Kukhanova, M.
|
|
1995
|
26 |
3 |
p. A281-
1 p.
|
artikel
|
| 74 |
Differential effects on the binding of the transcription factor, AP-1, to its gognate DNA sequence containing the nucleoside analog FIAU
|
Staschke, K.A.
|
|
1995
|
26 |
3 |
p. A291-
1 p.
|
artikel
|
| 75 |
3-dimensional structure studies of thiadiazole-derivatives for anti-HIV-1 RT activity
|
Nagano, H.
|
|
1995
|
26 |
3 |
p. A269-
1 p.
|
artikel
|
| 76 |
Direct quantitation of CMV DNA in leukocytes by bDNA signal amplification assay
|
|
|
1995
|
26 |
3 |
p. A322-
1 p.
|
artikel
|
| 77 |
Distribution to the brain, protein binding and physico-chemical properties of 5-substituted 3′-fluoro-uridine derivatives, studied by microdialysis
|
Borg, N
|
|
1995
|
26 |
3 |
p. A283-
1 p.
|
artikel
|
| 78 |
DMP450, a new cyclic urea inhibitor of HIV protease with potent in vitro antiviral activity
|
Winslow, D.L.
|
|
1995
|
26 |
3 |
p. A237-
1 p.
|
artikel
|
| 79 |
DNA vaccine protects mice from vaginitis and death due to herpes simplex virus type 2 (HSV-2)
|
|
|
1995
|
26 |
3 |
p. A233-
1 p.
|
artikel
|
| 80 |
Do some viruses encode selenoproteins? — Assessment of the theory in the light of current theoretical, experimental and clinical data
|
|
|
1995
|
26 |
3 |
p. A271-
1 p.
|
artikel
|
| 81 |
Drug interactions with mopyridone
|
Tantcheva, L.
|
|
1995
|
26 |
3 |
p. A353-
1 p.
|
artikel
|
| 82 |
Effect of HBPG on the clinical recurrences of ocular herpetic keratitis in squirrel monkeys
|
|
|
1995
|
26 |
3 |
p. A330-
1 p.
|
artikel
|
| 83 |
Effect of nucleosides on mitochondrial functions in HepG2 cells
|
|
|
1995
|
26 |
3 |
p. A292-
1 p.
|
artikel
|
| 84 |
Effect of polyanionic compounds on intracutaneous and intravaginal herpes virus infection in mice: Impact on the search for vaginal microbicides
|
Neyts, J.
|
|
1995
|
26 |
3 |
p. A333-
1 p.
|
artikel
|
| 85 |
Effect of protein binding on the pharmacodynamics of an HIV protease inhibitor
|
|
|
1995
|
26 |
3 |
p. A282-
1 p.
|
artikel
|
| 86 |
Effect of recombinant human and mouse interferons on herpes simplex virus type 1 replication in vitro and in vivo
|
|
|
1995
|
26 |
3 |
p. A316-
1 p.
|
artikel
|
| 87 |
Effect of S-28463 in reducing recurrent genital HSV-2 in guinea pigs
|
|
|
1995
|
26 |
3 |
p. A336-
1 p.
|
artikel
|
| 88 |
Effect of specific amino acid changes on the anti-HIV activity of NNRTIs: Confirmation of NNRTI-resistant virus subgrouping and selection of compounds for combination therapy
|
|
|
1995
|
26 |
3 |
p. A262-
1 p.
|
artikel
|
| 89 |
Effect of topical corticosteroids on the antiviral inhibitory activity of topical (S)-HPMPC in the AD5/NZ rabbit ocular model
|
|
|
1995
|
26 |
3 |
p. A354-
1 p.
|
artikel
|
| 90 |
Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells
|
Cinatl, J.
|
|
1995
|
26 |
3 |
p. A320-
1 p.
|
artikel
|
| 91 |
Effects of inhibitors of intracellular transport on the replication of Junin virus
|
|
|
1995
|
26 |
3 |
p. A356-
1 p.
|
artikel
|
| 92 |
Effects of the nucleoside-analogue antiviral agent ribavirin in persistently coxsackie-virus B3 infected human myocardial fibroblasts
|
Helm, A.
|
|
1995
|
26 |
3 |
p. A347-
1 p.
|
artikel
|
| 93 |
Efficacy and pharmacokinetics of topical HPMPC in a guinea pig model of genital herpes
|
|
|
1995
|
26 |
3 |
p. A341-
1 p.
|
artikel
|
| 94 |
Efficacy of peptide T in the rabbit model of HSV-1-induced keratitis
|
|
|
1995
|
26 |
3 |
p. A330-
1 p.
|
artikel
|
| 95 |
Efficacy of treatment with small dosage Interferon for hepatitis C virus
|
Zhangqi, Wu
|
|
1995
|
26 |
3 |
p. A290-
1 p.
|
artikel
|
| 96 |
Enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) adenine (PMEA) in drug sensitive and resistant cells
|
|
|
1995
|
26 |
3 |
p. A278-
1 p.
|
artikel
|
| 97 |
Enzymatic synthesis of 3′-azido-3′-deoxy-5′-O-(1,2-dihexadecanoyl-3-sn-phosphatidyl)thymidine involving commercially available phospholipase D type VII
|
Reitter, B.E.
|
|
1995
|
26 |
3 |
p. A247-
1 p.
|
artikel
|
| 98 |
Evaluation of aerosolized aprotinin therapy for influenza And parainfluenza infections in humans
|
Ovcharenko, A.V.
|
|
1995
|
26 |
3 |
p. A349-
1 p.
|
artikel
|
| 99 |
Evaluation of anti-AIDS drugs in conventional mice implanted with a permeable membrane (hollow fiber) device containing human T cells infected with HIV
|
|
|
1995
|
26 |
3 |
p. A274-
1 p.
|
artikel
|
| 100 |
Evaluation of antiviral agents against HHV-6 and HHV-7 in human cord blood cells
|
|
|
1995
|
26 |
3 |
p. A327-
1 p.
|
artikel
|
| 101 |
Evaluation of CRT healing components in two different topically treated cold sore animal models
|
Martin, A.
|
|
1995
|
26 |
3 |
p. A334-
1 p.
|
artikel
|
| 102 |
Famciclovir and valaciclovir treatment during acute HSV-1 infection of mice have markedly different effects on subsequent virus reaction from ganglia
|
|
|
1995
|
26 |
3 |
p. A232-
1 p.
|
artikel
|
| 103 |
Famciclovir: Effect on pain in herpes zoster
|
Dworkin, R.H.
|
|
1995
|
26 |
3 |
p. A344-
1 p.
|
artikel
|
| 104 |
Fluorometric measurement of reverse transcriptase activity with 4′,6-diamidino-2-phenylindole (DAPI)
|
|
|
1995
|
26 |
3 |
p. A252-
1 p.
|
artikel
|
| 105 |
Frequency of UL97 mutations related to ganciclovir resistance in clinical CMV isolates
|
|
|
1995
|
26 |
3 |
p. A293-
1 p.
|
artikel
|
| 106 |
Further studies into the mechanism of interaction of negatively charged human serum albumins with the V3 loop of the HIV-1 envelope protein Gp120
|
Kuipers, M.E.
|
|
1995
|
26 |
3 |
p. A281-
1 p.
|
artikel
|
| 107 |
Haemorrhagic fever with renal syndrome (KOrean haemorrhagic fever in Korea) a challenge in diagnosis & treatment: Report of 10 cases with atypical presentation
|
|
|
1995
|
26 |
3 |
p. A357-
1 p.
|
artikel
|
| 108 |
5-halo-6-alkoxy(or azido)-5,6-dihydro-3′-azido-3′-deoxythymidine diastereomers as potential produgs of 3′-azido-3′-deoxythymidine (AZT)
|
|
|
1995
|
26 |
3 |
p. A247-
1 p.
|
artikel
|
| 109 |
Heat shock induces HIV-1 replication in chronically infected promyelocyte cell line OM10.1: Implication of a new anti-HIV-1 assay in vitro
|
Hashimoto, K.
|
|
1995
|
26 |
3 |
p. A253-
1 p.
|
artikel
|
| 110 |
Herpes thymidine kinase inhibitors: Resolution and enantioselective synthesis of L-653,180 and water-soluble prodrugs
|
Von Langen, D.J.
|
|
1995
|
26 |
3 |
p. A307-
1 p.
|
artikel
|
| 111 |
Herpesvirus sensitivity to zovirax* (acyclovir, ACV) and other nucleoside analogues
|
|
|
1995
|
26 |
3 |
p. A308-
1 p.
|
artikel
|
| 112 |
High bioavailability and rapid distribution of penciclovir following an oral dose of famciclovir
|
Siederer, S.
|
|
1995
|
26 |
3 |
p. A339-
1 p.
|
artikel
|
| 113 |
Highly selective inhibitors of terminal deoxynucleotidyl transferase in cell free systems
|
Krayevsky, A.A.
|
|
1995
|
26 |
3 |
p. A356-
1 p.
|
artikel
|
| 114 |
High throughput screening for small molecule inhibitors of the HIV- Rev-RRE interaction
|
Arenas, J.E.
|
|
1995
|
26 |
3 |
p. A253-
1 p.
|
artikel
|
| 115 |
Homology modeling and molecular dynamics simulation studies of a hypothetical HIV-1 DNA binding protein and potential E2-like target site in the HIV-1 LTR
|
|
|
1995
|
26 |
3 |
p. A271-
1 p.
|
artikel
|
| 116 |
HSV-thymidine kinase: a molecular target for transfection imaging in gene therapy of cancer
|
|
|
1995
|
26 |
3 |
p. A307-
1 p.
|
artikel
|
| 117 |
Human bone marrow toxicity of a non-nucleoside pyrrolo[2,3-d]pyrimidine
|
|
|
1995
|
26 |
3 |
p. A337-
1 p.
|
artikel
|
| 118 |
Human cytomegalovirus (HCMV) strains selected under selective pressure of phosphonoformate (PFA) are resistant for both PFA and phosphonylmethoxyethyl (PME) derivatives in vitro
|
Snoeck, R.
|
|
1995
|
26 |
3 |
p. A320-
1 p.
|
artikel
|
| 119 |
Hydrocephalus induction in mice infected with herpes simplex virus type 2 after antiviral treatment
|
|
|
1995
|
26 |
3 |
p. A329-
1 p.
|
artikel
|
| 120 |
Improved purification of the HSV protease catalytic domain using immunoaffinity
|
|
|
1995
|
26 |
3 |
p. A314-
1 p.
|
artikel
|
| 121 |
Inducibility of squamous differentiation by interferons determines antigen presentation in HPV negative and positive keratinocytes in vivo and in vitro
|
Tyring, Stephen K.
|
|
1995
|
26 |
3 |
p. A354-
1 p.
|
artikel
|
| 122 |
Influence of the size of the virus inoculum on the efficacy of acyclovir (ACV) and implications for the treatment of herpes simplex labialis
|
|
|
1995
|
26 |
3 |
p. A317-
1 p.
|
artikel
|
| 123 |
Ingenol derivatives, ingredient of ‘Kansui’, are highly potent inhibitor of HIV
|
Fujiwara, M.
|
|
1995
|
26 |
3 |
p. A228-
1 p.
|
artikel
|
| 124 |
Inhibition of dihydropyrimidine dehydorogenase by 5-(E-2-bromovinyl)uracil (BV-Ura) and recovery of rat liver DPD activity after administration of BV-Ura or sorivudine
|
Machida, H.
|
|
1995
|
26 |
3 |
p. A341-
1 p.
|
artikel
|
| 125 |
Inhibition of Ebola virus by S-adenosylhomocysteine hydrolase inhibitors
|
Huggins, J.W.
|
|
1995
|
26 |
3 |
p. A301-
1 p.
|
artikel
|
| 126 |
Inhibition of HCMV DNA processing by a new class of anti-HCMV compounds (benzimidazole ribosides) is mediated through the UL89 gene product
|
Underwood, M.R.
|
|
1995
|
26 |
3 |
p. A295-
1 p.
|
artikel
|
| 127 |
Inhibition of HIV- and HBV-virus replication by 2,6-disubstituted purine 2′, 3′-dideoxynucleosides
|
|
|
1995
|
26 |
3 |
p. A245-
1 p.
|
artikel
|
| 128 |
Inhibition of HIV-1 infection of macrophages and H9 cells by free or liposome-encapsulated L-689,502, an inhibitor of the viral protease
|
Pretzer, E.
|
|
1995
|
26 |
3 |
p. A358-
1 p.
|
artikel
|
| 129 |
Inhibition of HPV-11 gene expression with chimeric methylphosphonate oligomers
|
Giachetti, C.
|
|
1995
|
26 |
3 |
p. A242-
1 p.
|
artikel
|
| 130 |
Inhibition of human immunodeficiency virus envelope glycoprotein-mediated cell fusion by synthetic phospholipid analogs
|
Kucera, L.
|
|
1995
|
26 |
3 |
p. A260-
1 p.
|
artikel
|
| 131 |
Inhibitors of varicella zoster virus thymidine kinase
|
|
|
1995
|
26 |
3 |
p. A296-
1 p.
|
artikel
|
| 132 |
Inhibitory effect of a series of protease inhibitors on influenza virus replication in vitro
|
Hosoya, M.
|
|
1995
|
26 |
3 |
p. A348-
1 p.
|
artikel
|
| 133 |
Interactions of reproductive ability of herpes simplex virus (HSV) type I and its variants, resistant to acyclovir (ACV) and phosphonoacetic acid (PAA) with proliferative activity of VERO cells
|
|
|
1995
|
26 |
3 |
p. A311-
1 p.
|
artikel
|
| 134 |
Interfering with HIV-1 replication by affecting cellular factors. HIV-1 inhibition by hydroxyurea
|
Lori, Franco
|
|
1995
|
26 |
3 |
p. A225-
1 p.
|
artikel
|
| 135 |
Intracellular activation and cytotoxicity of combinations of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine
|
|
|
1995
|
26 |
3 |
p. A255-
1 p.
|
artikel
|
| 136 |
Intracellular metabolism of the novel anti-herpesvirus agent 2-amino-7-[1,3-dihydroxy-2-propoxy)methyl]purine compound S2242 in non-infected and herpesvirus-infected cells
|
Neyts, J.
|
|
1995
|
26 |
3 |
p. A313-
1 p.
|
artikel
|
| 137 |
In vitro activity of bile acids on herpes simplex virus type-2 (HSV-2) infection
|
|
|
1995
|
26 |
3 |
p. A308-
1 p.
|
artikel
|
| 138 |
In vitro and in vivo enhancement of ddI activity against rauscher murine leukemia virus (RMuLV) by ribavirin
|
|
|
1995
|
26 |
3 |
p. A274-
1 p.
|
artikel
|
| 139 |
In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in HIV positive humans
|
Dornsife, R.E.
|
|
1995
|
26 |
3 |
p. A265-
1 p.
|
artikel
|
| 140 |
In vitro selection of HIV-1 resistance of ddI is not as efficient as for other antiretroviral drugs and yields virus which shows reduced cytophatic activity
|
Dianzani, F.
|
|
1995
|
26 |
3 |
p. A268-
1 p.
|
artikel
|
| 141 |
In vivo selection by monotherapy of HIV-1 variants resistant to multiple protease inhibitors
|
|
|
1995
|
26 |
3 |
p. A238-
1 p.
|
artikel
|
| 142 |
Isolation and initial characterization of a herpes simplex virus type 2 (HSV-2) strain with decreased sensitivity to Cidofovir
|
|
|
1995
|
26 |
3 |
p. A312-
1 p.
|
artikel
|
| 143 |
Kinetic analysis of human immunodeficiency virus type-1 reverse transcriptase with mutations at methionine 184 in the highly conserved YMDD region
|
|
|
1995
|
26 |
3 |
p. A267-
1 p.
|
artikel
|
| 144 |
Kinetic analysis of the interaction of inhibitors with RMuLV and human immunodeficiency virus (HIV) reverse transcriptases (RTs)
|
|
|
1995
|
26 |
3 |
p. A270-
1 p.
|
artikel
|
| 145 |
L-FMAU, a novel anti-HBV and anti-EBV agent
|
|
|
1995
|
26 |
3 |
p. A288-
1 p.
|
artikel
|
| 146 |
Lidakol cream vs zovirax ointment for the treatment of experimental dorsal cutaneous herpes simplex virus type 1(HSV-1) infection in the guinea pig
|
|
|
1995
|
26 |
3 |
p. A332-
1 p.
|
artikel
|
| 147 |
Long term antiviral combination chemotherapy for duck hepatitis B virus infection using ganciclovir and nalidixic acid in vivo
|
|
|
1995
|
26 |
3 |
p. A290-
1 p.
|
artikel
|
| 148 |
Mechanism of action of SCH 47802, an antipicornavirus molecule
|
Buontempo, P.
|
|
1995
|
26 |
3 |
p. A346-
1 p.
|
artikel
|
| 149 |
Mechanism of anti-human immunodeficiency virus (HIV) action of selected ATA-polymer analogues
|
Reymen, D.
|
|
1995
|
26 |
3 |
p. A258-
1 p.
|
artikel
|
| 150 |
Membrane permeation characteristics of the structurally related anti-HIV agents 1592U89 and (−)-carbovir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells
|
|
|
1995
|
26 |
3 |
p. A283-
1 p.
|
artikel
|
| 151 |
Metabolism of the carbocyclic analog of 2′-deoxyguanosine (CdG) in human cells
|
|
|
1995
|
26 |
3 |
p. A266-
1 p.
|
artikel
|
| 152 |
Mode of action of SDZ NIM 811, a non-immunosuppressive Cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1)
|
Rosenwirth, B.
|
|
1995
|
26 |
3 |
p. A227-
1 p.
|
artikel
|
| 153 |
Modulation of antiviral immune responses by exogenous cytokines effects of TNF-α, β, interleukin-1, interleukin-2 on the immunogenicity of an inactivated tick-born encephalitis vaccine
|
Kashentseva, E.A.
|
|
1995
|
26 |
3 |
p. A357-
1 p.
|
artikel
|
| 154 |
Multi-center safety and efficacy trial evaluating three times per week application of 1% and 5% topical imiquimod for the treatment of genital/perianal warts
|
|
|
1995
|
26 |
3 |
p. A244-
1 p.
|
artikel
|
| 155 |
Multiple drug effect analyses with confidence intervals for the evaluation of interactions of combined antiviral agents against hepatitis B virus
|
|
|
1995
|
26 |
3 |
p. A240-
1 p.
|
artikel
|
| 156 |
n-docosanol prevents vaginal transmission of SIVmac251 in rhesus macaques
|
Miller, C.J.
|
|
1995
|
26 |
3 |
p. A277-
1 p.
|
artikel
|
| 157 |
Negatively charged human serum albumins: A novel class of polyanionic proteins with a potent anti-HIV-I activity
|
Swart, P.J.
|
|
1995
|
26 |
3 |
p. A279-
1 p.
|
artikel
|
| 158 |
Negatively charged human serum albumins: Inhibition of replication of primary HIV-1 isolates and biomolecular interaction with Gp120
|
Kuipers, M.E.
|
|
1995
|
26 |
3 |
p. A280-
1 p.
|
artikel
|
| 159 |
New classes of reagents that attack conserved and chemically reactive zinc fingers in retroviral nucleocapsid proteins: A strategy for rational drug design
|
|
|
1995
|
26 |
3 |
p. A235-
1 p.
|
artikel
|
| 160 |
Novel assay system for hepatitis C virus serine protease inhibitors
|
Inoue, Hiroshi
|
|
1995
|
26 |
3 |
p. A289-
1 p.
|
artikel
|
| 161 |
Novel mutations in the reverse transcriptase of HIV-1 reduce susceptibility to phosphonoformate in laboratory and clinical isolates
|
|
|
1995
|
26 |
3 |
p. A236-
1 p.
|
artikel
|
| 162 |
Nucleoside anti-HIV efficacy in the xenotransplanted nude mouse model
|
|
|
1995
|
26 |
3 |
p. A239-
1 p.
|
artikel
|
| 163 |
One-month oral toxicity studies of a protease Inhibitor (ABT-987) in rats and Dogs
|
|
|
1995
|
26 |
3 |
p. A286-
1 p.
|
artikel
|
| 164 |
On the bioisosteric potential of the pyridazine core in the systematic structural modification of antiviral agents
|
Heinisch, G.
|
|
1995
|
26 |
3 |
p. A250-
1 p.
|
artikel
|
| 165 |
Optimization of antiviral and kinetic properties of PETT compounds, a class of potent non-nucleoside HIV-RT inhibitors
|
Johansson, N.-G.
|
|
1995
|
26 |
3 |
p. A257-
1 p.
|
artikel
|
| 166 |
Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial
|
Wutzler, P.
|
|
1995
|
26 |
3 |
p. A302-
1 p.
|
artikel
|
| 167 |
Pathogenesis of drug resistant clinical HSV-2 isolates in the guinea pig model of genital herpes
|
|
|
1995
|
26 |
3 |
p. A335-
1 p.
|
artikel
|
| 168 |
Penciclovir: A novel nucleoside analogue with potent activity against duck hepatitis B virus in vivo
|
|
|
1995
|
26 |
3 |
p. A242-
1 p.
|
artikel
|
| 169 |
Peptide disruption of protein-protein complexes: a novel strategy for antiviral therapy
|
Palú, G.
|
|
1995
|
26 |
3 |
p. A315-
1 p.
|
artikel
|
| 170 |
Peptidomimetic ribonucleotide reductase inhibitors in the treatment of herpes simplex keratitis in mice
|
Garneau, M.
|
|
1995
|
26 |
3 |
p. A331-
1 p.
|
artikel
|
| 171 |
Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice
|
Kuipers, M.E.
|
|
1995
|
26 |
3 |
p. A280-
1 p.
|
artikel
|
| 172 |
Pharmacokinetics and distribution of penciclovir to the brain and muscle in the rat studied by microdialysis
|
Ståhle, L
|
|
1995
|
26 |
3 |
p. A339-
1 p.
|
artikel
|
| 173 |
Pharmacokinetics in mice of bis(POM)-PMEA, the bis(pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl)adenine
|
Naesens, L.
|
|
1995
|
26 |
3 |
p. A277-
1 p.
|
artikel
|
| 174 |
Pharmacokinetics of 3′-fluoro-guanosine (FLG) in cynomolgus monkeys
|
Borg, N
|
|
1995
|
26 |
3 |
p. A284-
1 p.
|
artikel
|
| 175 |
Pharmacokinetics of penciclovir following oral famciclovir in subjects with mild renal impairment
|
Scott, S.
|
|
1995
|
26 |
3 |
p. A340-
1 p.
|
artikel
|
| 176 |
Phosphonate derivatives of six membered-ring nucleosides: Synthesis and antiviral evaluation
|
|
|
1995
|
26 |
3 |
p. A226-
1 p.
|
artikel
|
| 177 |
Phosphonoacid prodrugs with greatly increased antiviral activity in HCMV-infected cells, in vitro
|
|
|
1995
|
26 |
3 |
p. A294-
1 p.
|
artikel
|
| 178 |
Phosphorylation of HIV-1 matrix protein is necessary for nuclear targeting of viral preintegration complex
|
|
|
1995
|
26 |
3 |
p. A226-
1 p.
|
artikel
|
| 179 |
Phosphorylation of 9-(2-phosphonyimethoxyethyl)adenine (PMEA) is greater in macrophages than in replicating lymphocytes and fibroblasts
|
Balestra, E.
|
|
1995
|
26 |
3 |
p. A275-
1 p.
|
artikel
|
| 180 |
Plant polysaccharide antiviral agents from Astragalus and Sterculia species
|
|
|
1995
|
26 |
3 |
p. A353-
1 p.
|
artikel
|
| 181 |
PMEA has immunomodulatory activity and inhibits reverse transcriptase in the Rauscher murine leukemia virus (RMuLV) model
|
|
|
1995
|
26 |
3 |
p. A276-
1 p.
|
artikel
|
| 182 |
Potent anti-viral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36/37
|
Pari, G.S.
|
|
1995
|
26 |
3 |
p. A295-
1 p.
|
artikel
|
| 183 |
Potentiating effect of dextran sulphate on the antiviral activity of acyclovir and BVDU in the treatment of herpetic keratitis in rabbits
|
|
|
1995
|
26 |
3 |
p. A331-
1 p.
|
artikel
|
| 184 |
Potent topical anti-herpes activity of a lipophilic phosphorus prodrug for the antiviral agent PMEA
|
Glazier, A.
|
|
1995
|
26 |
3 |
p. A306-
1 p.
|
artikel
|
| 185 |
Preclinical safety assessment of valtrex* (valaciclovir, VACV) the l-valyl ester of acyclovir (ACV)
|
|
|
1995
|
26 |
3 |
p. A342-
1 p.
|
artikel
|
| 186 |
Preparation and anti-viral activity of oligoribonucleotides containing 5-fluorouridine
|
|
|
1995
|
26 |
3 |
p. A251-
1 p.
|
artikel
|
| 187 |
Preparation and characterization of conjugates of (modified) human serum albumin liposomes: Drug carriers with an intrinsic anti-HIV activity
|
Kamps, J.A.A.M.
|
|
1995
|
26 |
3 |
p. A279-
1 p.
|
artikel
|
| 188 |
Preparation of enantiomerically pure branched DNA for shape specific binding of RNA hairpin loops
|
|
|
1995
|
26 |
3 |
p. A251-
1 p.
|
artikel
|
| 189 |
Prevention and treatment of experimental genital herpes simplex virus type 2 (HSV-2) infections with topical HPMPC
|
|
|
1995
|
26 |
3 |
p. A334-
1 p.
|
artikel
|
| 190 |
Prophylactic therapy of respiratory syncytial virus (RSV) infection of rhesus monkeys with monoclonal IgA antibody to RSV
|
Traina-Dorge, V.
|
|
1995
|
26 |
3 |
p. A299-
1 p.
|
artikel
|
| 191 |
Psychosocial impact of genital herpes in guinea pigs: effect of 0-2B9¼ therapy
|
|
|
1995
|
26 |
3 |
p. A336-
1 p.
|
artikel
|
| 192 |
Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase
|
|
|
1995
|
26 |
3 |
p. A314-
1 p.
|
artikel
|
| 193 |
Pyrryl-aryl-sulphones: synthesis and anti-HIV activity
|
De Montis, A.
|
|
1995
|
26 |
3 |
p. A261-
1 p.
|
artikel
|
| 194 |
QC-PCR accurate determination of rabbit genomic DNA: Evaluation of VZV load in the rabbit ocular infection model
|
|
|
1995
|
26 |
3 |
p. A325-
1 p.
|
artikel
|
| 195 |
QSAR study of nucleoside analogs with anti-HIV activity using molecular similarity analysis and structure-activity maps
|
Tsai, C.C.
|
|
1995
|
26 |
3 |
p. A254-
1 p.
|
artikel
|
| 196 |
Qualitative and quantitative differences between intracellular penciclovir (PCV) triphosphate (PCVTP) and acyclovir (ACV) triphosphate (ACVTP) in a human schwannoma cell line (SW) infected with varicella zoster virus (VZV)
|
|
|
1995
|
26 |
3 |
p. A338-
1 p.
|
artikel
|
| 197 |
Rapid assay for determining the mode of action of compounds effective against human cytomegalovirus (HCMV)
|
|
|
1995
|
26 |
3 |
p. A318-
1 p.
|
artikel
|
| 198 |
Rapid determination of antiviral sensitivity of human cytomegalovirus
|
Ljungdahl Ståhle, E
|
|
1995
|
26 |
3 |
p. A318-
1 p.
|
artikel
|
| 199 |
Rapid in vivo development of influenza a (H3N2) virus resistance to amantadine and rimantadine
|
|
|
1995
|
26 |
3 |
p. A348-
1 p.
|
artikel
|
| 200 |
Red-blood cells mediated drug delivery to phagocytic cells as a selective therapeutic approach to infections by HIV and herpesviruses
|
Perno, CF.
|
|
1995
|
26 |
3 |
p. A282-
1 p.
|
artikel
|
| 201 |
Resistance of HSV-1 to peptidomimetic ribonucleotide reductase inhibitors: Selection and characterization of mutant isolates
|
|
|
1995
|
26 |
3 |
p. A231-
1 p.
|
artikel
|
| 202 |
Safe coadministration of famciclovir and zidovudine to HIV positive patients
|
|
|
1995
|
26 |
3 |
p. A287-
1 p.
|
artikel
|
| 203 |
Safety of didanosine plus stavudine combination therapy in HIV-infected subjects in a pilot randomized double-blinded trial
|
|
|
1995
|
26 |
3 |
p. A302-
1 p.
|
artikel
|
| 204 |
4(S)(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol: Synthesis, enzymology and anti-HIV studies
|
Nair, V.
|
|
1995
|
26 |
3 |
p. A249-
1 p.
|
artikel
|
| 205 |
Selection and characterization of HCMV resistant to the benzimidazole ribonucleoside TCRB
|
|
|
1995
|
26 |
3 |
p. A319-
1 p.
|
artikel
|
| 206 |
Selective elimination of cytomegalovirus infected cells by immunotoxins targeted with various antibodies linked to ricin A chain or gelonin
|
|
|
1995
|
26 |
3 |
p. A323-
1 p.
|
artikel
|
| 207 |
Selective liver targeting of a derivatized antiviral nucleoside analogue by recombinant chylomicrons
|
|
|
1995
|
26 |
3 |
p. A241-
1 p.
|
artikel
|
| 208 |
Sensitivities of human cytomegalovirus (HCMV) clinical isolates to cidofovir
|
|
|
1995
|
26 |
3 |
p. A319-
1 p.
|
artikel
|
| 209 |
Sequence within the HIV-1 LTR required for strand transfer by integrase in vitro
|
Hazuda, D.J.
|
|
1995
|
26 |
3 |
p. A272-
1 p.
|
artikel
|
| 210 |
Sequential ascending multiple-dose safety and pharmacokinetic study of oral lobucavir (BMS-180194) in asymptomatic volunteers seropositive for HIV and CMV
|
|
|
1995
|
26 |
3 |
p. A296-
1 p.
|
artikel
|
| 211 |
Significance of high skin fluxes produced by acyclovir topical formulations for achieving therapeutic levels of drug at the target site in the treatment of cutaneous HSV-1 infections in hairless mice: A closer look at the C* concept
|
|
|
1995
|
26 |
3 |
p. A332-
1 p.
|
artikel
|
| 212 |
Some nucleoside analogs with anti-human immunodeficiency virus activity inhibit Replication of Epstein-Barr virus
|
Mar, E.-C.
|
|
1995
|
26 |
3 |
p. A325-
1 p.
|
artikel
|
| 213 |
Sorivudine (BV-ara-U) for the treatment of complicated refractory varicella zoster virus infection in HIV-infected patients
|
|
|
1995
|
26 |
3 |
p. A343-
1 p.
|
artikel
|
| 214 |
Specific anti-cytomegaloviral activity of methotrexate associated with preferential accumulation of drug by infected cells
|
|
|
1995
|
26 |
3 |
p. A321-
1 p.
|
artikel
|
| 215 |
Spontaneous reactivation of acyclovir resistant (ACVr) thymidine kinase deficient (T K−) herpes simplex virus type 2 (HSV 2) is still dependent upon viral TK expression
|
Sasadeusz, J.J.
|
|
1995
|
26 |
3 |
p. A327-
1 p.
|
artikel
|
| 216 |
Squamous differentiation in HPV negative and positive keratinocytes determines the extent of interferon-induced growth arrest
|
|
|
1995
|
26 |
3 |
p. A355-
1 p.
|
artikel
|
| 217 |
Stereoselective synthesis of (S)- and (R)-penciclovir triphosphate and their activity against viral enzymes
|
|
|
1995
|
26 |
3 |
p. A304-
1 p.
|
artikel
|
| 218 |
Stereospecific synthesis and antiviral evaluation of purine nucleoside L-enantiomers: β-L-Ara-A, 3′-deoxy-β-L-Ribo-A and β-L-Lyxo-A
|
Imbach, J.-L.
|
|
1995
|
26 |
3 |
p. A246-
1 p.
|
artikel
|
| 219 |
Structure-activity relationships studies in TSAO-T derivatives modified at the 2′- and 5′- positions of the sugar moiety
|
Ingate, S.T.
|
|
1995
|
26 |
3 |
p. A249-
1 p.
|
artikel
|
| 220 |
Structure-activity relationship studies for various oxathiin carboxanilide derivatives modified in the oxathiin moiety against wild-type and mutant human immunodeficiency virus type 1 strains
|
Balzarini, J.
|
|
1995
|
26 |
3 |
p. A261-
1 p.
|
artikel
|
| 221 |
Study of human immunodeficiency virus resistance to the acyclic nucleoside phosphonate analogs
|
|
|
1995
|
26 |
3 |
p. A278-
1 p.
|
artikel
|
| 222 |
Sulfated xylogalactans from marine algae useful as anti HSV-1 agents
|
|
|
1995
|
26 |
3 |
p. A306-
1 p.
|
artikel
|
| 223 |
Suppression of hematopoietic support function is associate with over-expression of IL-4 and TGFβ1 in LP-BM5 MuLV infected Stromal cell lines
|
|
|
1995
|
26 |
3 |
p. A273-
1 p.
|
artikel
|
| 224 |
SV40 DNA hybridization assay: Use as a primary cell-based screen for antiviral inhibitors of human papovaviruses
|
|
|
1995
|
26 |
3 |
p. A243-
1 p.
|
artikel
|
| 225 |
Synthesis and antiviral activity of novel phosphonomethyl ether nucleosides
|
Bischofberger, N.
|
|
1995
|
26 |
3 |
p. A294-
1 p.
|
artikel
|
| 226 |
Synthesis and biological evaluation of new carbocyclic 2′,3′-didehydro-2′,3′-dideoxy and 3′-deoxy-2′-fluoropyrimidine and purinenucleosides
|
Guedj, R.
|
|
1995
|
26 |
3 |
p. A305-
1 p.
|
artikel
|
| 227 |
Synthesis and structure-activity relationship of thiadiazole derivatives, novel nonnucleoside inhibitors of HIV-1
|
Yokota, T.
|
|
1995
|
26 |
3 |
p. A258-
1 p.
|
artikel
|
| 228 |
Synthesis, anti-human immunodeficiency virus activities, cytotoxicities, and decomposition pathways of the bis(SATE)phosphotriester derivatives of AZT
|
Imbach, J.-L.
|
|
1995
|
26 |
3 |
p. A259-
1 p.
|
artikel
|
| 229 |
Synthesis of acyclic nucleotide analogues derived from 2-(aminomethyl)purine bases
|
Holý, A.
|
|
1995
|
26 |
3 |
p. A305-
1 p.
|
artikel
|
| 230 |
Synthetic peptides from conserved regions of human parainfluenza type 3 virus fusion protein are potent inhibitors of viral fusion
|
|
|
1995
|
26 |
3 |
p. A352-
1 p.
|
artikel
|
| 231 |
Synthetic peptides from conserved regions of measles virus fusion proteins are potent inhibitors of viral fusion
|
|
|
1995
|
26 |
3 |
p. A352-
1 p.
|
artikel
|
| 232 |
Synthetic peptides from conserved regions of respiratory syncytial virus fusion (F) protein are potent inhibitors of viral fusion
|
|
|
1995
|
26 |
3 |
p. A350-
1 p.
|
artikel
|
| 233 |
Synthetic peptides from conserved regions of RSV, HPIV-3, and MeV fusion proteins are potent antivirals (inhibitors of viral fusion)
|
|
|
1995
|
26 |
3 |
p. A298-
1 p.
|
artikel
|
| 234 |
The consequence of incorporation of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine by human cytomegalovirus DNA polymerase on DNA elongation
|
|
|
1995
|
26 |
3 |
p. A321-
1 p.
|
artikel
|
| 235 |
The cyclic congener of cidofovir has reduced nephrotoxicity in three species
|
Hitchock, M.J.M.
|
|
1995
|
26 |
3 |
p. A358-
1 p.
|
artikel
|
| 236 |
The development of an in vitro antiviral susceptibility assay using alamar blue
|
|
|
1995
|
26 |
3 |
p. A309-
1 p.
|
artikel
|
| 237 |
The efficacy of steroids and acyclovir therapy of herpes zoster in the elderly
|
|
|
1995
|
26 |
3 |
p. A303-
1 p.
|
artikel
|
| 238 |
The in vitro activity of cidofovir against acyclovir-resistant and foscarnet-resistant herpes simplex virus (HSV) isolates
|
|
|
1995
|
26 |
3 |
p. A310-
1 p.
|
artikel
|
| 239 |
The phosphonate ganciclovir derivative SR 3745A demonstrates severe toxicity in cell culture and in guinea pigs
|
|
|
1995
|
26 |
3 |
p. A337-
1 p.
|
artikel
|
| 240 |
Therapeutic effect of L-HSA-AraAMP on serum DHBV-DNA in DHBV infected duckling
|
Yang, Hui-wu
|
|
1995
|
26 |
3 |
p. A359-
1 p.
|
artikel
|
| 241 |
The SCID-Ra model for evaluation of inhibitors of papillomaviruses
|
Lobe, D.C.
|
|
1995
|
26 |
3 |
p. A243-
1 p.
|
artikel
|
| 242 |
The synthesis and biological evaluation of phosphate triester alkyl lysophospholipids (ALPs) as potential antineoplastic and anti-HIV agents
|
Wang, Y.
|
|
1995
|
26 |
3 |
p. A246-
1 p.
|
artikel
|
| 243 |
The synthesis of novel phospholipids with potential antineoplastic and antiviral activity
|
Wilson, MS.
|
|
1995
|
26 |
3 |
p. A250-
1 p.
|
artikel
|
| 244 |
Thiadiazole derivatives as highly potent inhibitor of human immunodeficiency virus type 1 (HIV-1)
|
Fujiwara, M.
|
|
1995
|
26 |
3 |
p. A254-
1 p.
|
artikel
|
| 245 |
Thiocarboxanilide derivatives synergistically suppress the breakthrough of human immunodeficiency virus type I (HIV-1) in CEM cell cultures when used in combination with TSAO derivatives
|
Balzarini, J.
|
|
1995
|
26 |
3 |
p. A237-
1 p.
|
artikel
|
| 246 |
Tissue distribution and bioavailability of cyclic HPMPC, an intracellular prodrug of HPMPC
|
Lee, W.A.
|
|
1995
|
26 |
3 |
p. A340-
1 p.
|
artikel
|
| 247 |
Twice daily intranasal GG167 for experimental influenza A
|
|
|
1995
|
26 |
3 |
p. A300-
1 p.
|
artikel
|
| 248 |
Ultratrace determination of penciclovir-triphosphate (PCV-TP) in a herpes simplex virus type 1 (HSV-1)-infected cell line using flow-injection electrospray ionization tandem mass spectrometry (MS-MS)
|
|
|
1995
|
26 |
3 |
p. A232-
1 p.
|
artikel
|
| 249 |
Unique purine crossover activation pathway for the potent anti-HIV agent 1592U89
|
Faletto, M.B.
|
|
1995
|
26 |
3 |
p. A262-
1 p.
|
artikel
|
| 250 |
Use of drug combinations for selection of human immunodeficiency virus type I (HIV-1) variants with decreased sensitivity to hydroxyethylurea isostere containing protease inhibitors in vitro
|
Smidt, M.L.
|
|
1995
|
26 |
3 |
p. A256-
1 p.
|
artikel
|
| 251 |
1592U89 succinate — a potent, selective anti-HIV carbocyclic nucleoside
|
|
|
1995
|
26 |
3 |
p. A228-
1 p.
|
artikel
|
| 252 |
1592U89 succinate — preclinical toxicological and disposition studies and preliminary clinical pharmacokinetics
|
|
|
1995
|
26 |
3 |
p. A229-
1 p.
|
artikel
|
| 253 |
Valtrex* (Valaciclovir, VACV) for the treatment of recurrent genital herpes
|
|
|
1995
|
26 |
3 |
p. A234-
1 p.
|
artikel
|
| 254 |
WIN 63843, a metabolically stable broad spectrum antipicornaviral compound
|
|
|
1995
|
26 |
3 |
p. A345-
1 p.
|
artikel
|
| 255 |
Zidovudine (AZT) treatment of liver cells causes accumulation of intracellular lipid droplets, and phosphorylated zidovudine intracellularly increases lactate in medium, and inhibits mitochondrial DNA polymerase-γ
|
Lewis, E.
|
|
1995
|
26 |
3 |
p. A264-
1 p.
|
artikel
|
| 256 |
Zidovudine-uridine dimer and its hexadecyl ester: Synthesis, antiviral evaluation and pharmacokinetics
|
|
|
1995
|
26 |
3 |
p. A285-
1 p.
|
artikel
|
Tijdschrift beschrijving